pcloudy.png
Wednesday April 8th, 2020 12:29PM

Drugmaker backpedals on specialty status for COVID-19 drug

By The Associated Press

WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.

Gilead Sciences said it will ask U.S. regulators to revoke the so-called “orphan drug” status it received for its experimental drug remdesivir. The status would have entitled the company to financial incentives and exclusive marketing intended for rare disease treatments.

The Food and Drug Administration granted the company's request for the designation on Monday, noting that COVID-19 qualified as a rare disease under U.S. rules, since fewer than 200,000 Americans are infected.

But experts and public advocates blasted Gilead for seeking the status.

“COVID-19 is anything but a rare disease,” stated a letter sent to the company earlier Wednesday by more than 50 consumer and patient advocacy groups. The groups noted that millions of Americans are expected to eventually be infected with the virus. As of Wednesday, cases in the U.S. topped 61,000.

Gilead said in a statement Wednesday afternoon that it asked the FDA to rescind the orphan drug designation and that the company "recognizes the urgent public health needs posed by the COVID-19 pandemic.”

Currently, there are no FDA-approved drugs, vaccines or specific treatments for the coronavirus. A few existing and experimental drugs are being studied, and vaccines are being developed.

Remdesivir, originally developed for Ebola, is being tested in at least five experiments. The drug interferes with viral reproduction and has shown some promise in lab and animal studies against other coronaviruses that cause similar diseases, MERS and SARS.

The drug has been given to hundreds of COVID-19 patients thus far, but rigorous studies are needed to determine if it works before it is approved.

Congress created the orphan drug program more than 35 years ago to encourage companies to develop drugs for niche diseases and conditions Since then, filing for the program has become a standard industry tactic.

Under FDA rules, manufacturers of orphan drugs receive seven years of exclusive U.S. marketing rights and tax credits on their research and development costs.

For most people, the new coronavirus causes mild or moderate symptoms, such as fever and cough that clear up in two to three weeks. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia.

___

Follow Matthew Perrone on Twitter: www.twitter.com/AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, AP Health, AP Business, AP Business - Industries, AP Business - Health Care
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
New York mobilizes against onslaught from the virus
Just days after New York leaders ordered people to stay home, authorities are mobilizing to head off a potential public health disaster in the big city
4:11PM ( 16 minutes ago )
'We are collapsing': Virus pummels medics in Spain and Italy
The coronavirus is waging a war of attrition against health care workers around the world
3:58PM ( 29 minutes ago )
Primary purgatory with no 12th Democratic debate on horizon
There's no 12th Democratic presidential debate on the horizon now that the nominating process is in a holding pattern because of the coronavirus pandemic
3:56PM ( 31 minutes ago )
Associated Press (AP)
What you need to know today about the virus outbreak
The White House and Senate leaders of both parties have agreed on unprecedented emergency legislation to rush sweeping aid totaling some $2 trillion to businesses, workers and a health care system slammed by the coronavirus pandemic
3:07PM ( 1 hour ago )
Rural America watches pandemic erupt in cities as fear grows
The pandemic's toll in big cities like New York, Seattle and San Francisco has dominated headlines, but large swaths of rural America are also deeply affected
2:38PM ( 1 hour ago )
Washington agrees on unrivaled $2 trillion virus rescue bill
The White House and Senate leaders have reached agreement on a $2 trillion measure to rush aid to businesses, workers and a health care system slammed by the coronavirus pandemic
2:06PM ( 2 hours ago )
AP Health
First signs of disruption appear in housing; markets 'calm'
Economists have been waiting for the first signs of virus-related disruptions in housing with the expectation that they will be seismic
3:25PM ( 1 hour ago )
The Latest: Argentine cyclist in UAE recovers from virus
Argentine cyclist Max Richeze has been released from a hospital in the United Arab Emirates
3:22PM ( 1 hour ago )
Global pandemic postpones this year's glitzy Tony Awards
With Broadway shuttered amid the coronavirus pandemic, producers of the annual Tony Awards have postponed this year's celebration of American theater
3:16PM ( 1 hour ago )
AP Business
First signs of disruption appear in housing; markets "calm"
Economists have been waiting for the first signs of virus-related disruptions in housing with the expectation that they will be seismic
11:30AM ( 4 hours ago )
Of America and sacrifice: Is the country ready to step up?
For most Americans alive today, the idea of a shared national sacrifice is a collective abstraction
10:00AM ( 6 hours ago )
10 Things to Know for Today
Get ready for Wednesday, March 25, with a few things to know about the day’s news from The Associated Press
7:04AM ( 9 hours ago )
AP Business - Industries
Talks on $2T bill to ease economic pain from virus drag on
Unprecedented legislation to rush sweeping aid to businesses, workers and a health care system slammed by the coronavirus remains snagged on Capitol Hill
11:33PM ( 16 hours ago )
Potential coronavirus treatment granted rare disease status
The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators
9:11PM ( 19 hours ago )
'A bullet train': Virus peak may come soon, swamp hospitals
Gov. Andrew Cuomo has sounded his most dire warning yet about the coronavirus pandemic
8:54PM ( 19 hours ago )
AP Business - Health Care
New York mobilizes against onslaught from the virus
Just days after New York leaders ordered people to stay home, authorities are mobilizing to head off a potential public health disaster in the big city
4:11PM ( 16 minutes ago )
'We are collapsing': Virus pummels medics in Spain and Italy
The coronavirus is waging a war of attrition against health care workers around the world
3:58PM ( 29 minutes ago )
Primary purgatory with no 12th Democratic debate on horizon
There's no 12th Democratic presidential debate on the horizon now that the nominating process is in a holding pattern because of the coronavirus pandemic
3:56PM ( 31 minutes ago )
The Latest: Texas Rangers manager thanks health care workers
Texas Rangers manager Chris Woodward and his wife Erin, a trauma nurse, have recorded a message thanking first responders and health care workers
3:54PM ( 34 minutes ago )
Aid group says Mideast lockdowns hinder humanitarian efforts
An international aid group says closures aimed at containing the coronavirus pandemic are preventing it from reaching 300,000 people in conflict zones across the Middle East
3:49PM ( 38 minutes ago )